Silchester International Investors LLP Merck & Co., Inc. Transaction History

Silchester International Investors LLP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 08, 2019	SELL	$65.24 - $75.71 $5.75 Million - $6.67 Million	-88,137 Closed	0 $0
Q3 2018 Nov 13, 2018	BUY	$57.69 - $67.84 $2.81 Million - $3.3 Million	48,627 Added 123.08%	88,137 $6.25 Million
Q2 2018 Aug 10, 2018	BUY	$50.83 - $59.72 $211,147 - $248,076	4,154 Added 11.75%	39,510 $2.4 Million
Q1 2018 May 14, 2018	BUY	$50.96 - $59.23 $491,814 - $571,628	9,651 Added 37.55%	35,356 $1.93 Million
Q4 2017 Feb 13, 2018	BUY	$51.62 - $61.64 $1.33 Million - $1.58 Million	25,705	25,705 $1.45 Million

3,827

1.87B

15.6M

13.7M

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $252B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

Get notified when there are updates to the investment portfolio of Silchester International Investors LLP, based on Form 13F filings with the SEC.

Stay updated on Silchester International Investors LLP with notifications on news.